Researchers at the University of Pittsburgh have analyzed genomes of 3,600 pancreatic tumours worldwide in an effort to diagnose pancreatic cancer at earlier stages and thus increase odds of survival. According to study lead author Dr. Aatur Singh, "every pancreatic cancer is different. Developing a molecular profile of each patient's tumor could help determine best treatments."
To read more about this study, click here.
No comments:
Post a Comment